Who invested in Caspian Therapeutics?
Caspian Therapeutics's investors include BVF Partners, Invus, Eli Lilly, T1D Fund and Biotech Entrepreneurs, and 3 more on record. BVF Partners led its latest round.
Who invested in Caspian Therapeutics
One round we have observed, with the 8 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 2 months ago
Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2026, from 1 source
- Latest round
- Series A, $50MSept 2026
- Led by
- BVF Partners
- Investors
- 8 (1 led)
The rounds
- Sept 2026Series A$50M
- BVF PartnersLead
Invus
Eli Lilly
T1D Fund
Kura Oncology
Montanova- Biotech Entrepreneurs
- members of Kura's leadership team
Reported by QRM CapitalSEC filing: $50M sold
Everyone who backed them
BVF PartnersVC firm1round, led 1
Biotech EntrepreneursVC firm1round
members of Kura's leadership teamVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Caspian Therapeutics
How much has Caspian Therapeutics raised?
Caspian Therapeutics has raised $50M across 1 round since 2026.
When did Caspian Therapeutics last raise?
Caspian Therapeutics's most recent round was a Series A of $50M in Sept 2026, led by BVF Partners.
What was Caspian Therapeutics's biggest round?
Its most recent round, $50M in Sept 2026, is also its largest on record.
Who backed Caspian Therapeutics first?
Caspian Therapeutics's first round on record, in Sept 2026, was backed by BVF Partners, Invus and Eli Lilly and 5 others.
What stage is Caspian Therapeutics at?
Caspian Therapeutics's latest named round is a Series A, in Sept 2026.
Who led Caspian Therapeutics's rounds?
BVF Partners led the Series A in 2026.
Companies like Caspian Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.